Diaaeldin Mohamed Abdelkawi Elimam

Diaaeldin Mohamed Abdelkawi Elimam

Auto-generated profile, based on publicly available information

Diaaeldin Mohamed Abdelkawi Elimam

Department of Pharmacognosy, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2022 in RSC Advances
Verified
Journal Article
Open access
PDF file
TATarfah Al-Warhi
Tarfah Al-Warhi
DEDiaaeldin M. Elimam
Diaaeldin M. Elimam
ZEZainab M. Elsayed
Zainab M. Elsayed
MAMarwa Abdel-Aziz
Marwa Abdel-Aziz
Raed M. MakladRaed M. Maklad
Raed M. Maklad
Wagdy Mohamed EldehnaWagdy Mohamed Eldehna
Wagdy Mohamed Eldehna
Microbial Multidrug Resistance (MDR) is an emerging global crisis. Derivatization of natural or synthetic scaffolds is among the most reliable strategies to search for and obtain novel antimicrobial agents for the treatment of MDR infections. Here, we successfully manipulated the synthetically flexible isatin moieties to synthesize 22 thiazolyl-pyrazolines hybrids, and assessed their potential antimicrobial activities in vitro against various MDR pathogens, using the broth microdilution calorimetric XTT reduction method. We chose 5 strains to represent the major MDR microorganisms, viz: Methicillin-resistant S. aureus (MRSA), and Vancomycin-resistant E. faecalis (VRE) as Gram-positive bacteria; Carbapenem-resistant K. pneumonia (CRKP), and Extended-spectrum beta-lactamase E. coli (ESBL-E), as Gram-negative bacteria; and Fluconazole-resistant C. albicans (FRCA), as a yeast-like unicellular fungus. The cytotoxicity of compounds 9f and 10h towards mammalian lung fibroblast (MRC-5) cells demonstrated their potential satisfactory safety margin as represented by their relatively high IC50 values. The target compounds showed promising anti-MDR activities, suggesting they are potential leads for further development and in vivo studies.

16 April 2018 in Natural Product Research
Verified
Journal Article
Closed access
Fatma M. Abdel BarFatma M. Abdel Bar
Fatma M. Abdel Bar
DEDiaaeldin M Elimam
Diaaeldin M Elimam
AMAmira S Mira
Amira S Mira
Fardous F. El-SendunyFardous F. El-Senduny
Fardous F. El-Senduny
FBFarid A Badria
Farid A Badria
Phytochemical study of the aerial part of Pulicaria undulata L. led to the isolation of nine compounds. The structure of 1β,2α,3β,19α,23-pentahydroxy-urs-12-en-28-oic acid (4) was revised and confirmation of the stereochemical configuration of the hydroxyl groups was established using NOESY and selective decoupling experiments. The other compounds were identified as 1,2-dehydro-1,10α-dihydropseudoivalin (1), axillarin (2), grandifloric acid-15-β-glucoside (3), myrianthic acid (5), caffeic acid (6), quercetin (7), paniculoside IV (8) and caffeic anhydride (9). The structures were characterized by 1 D, 2 D NMR spectroscopy and confirmed with HRMS. Antimicrobial and antiquorum-sensing activities of the different extracts and isolated compounds of the plant were investigated. Generally, the phenolic rather than the terpenoidal compounds exhibited remarkable antimicrobial and antiquorum-sensing activity.

1 January 2017 in Journal of Apitherapy
Verified
Journal Article
Closed access
FBFarid Badria
Farid Badria
HFHassan Fathy
Hassan Fathy
AFAshraf Fatehe
Ashraf Fatehe
DEDiaaeldin Elimam
Diaaeldin Elimam
MGMohamed Ghazy
Mohamed Ghazy

1 January 2017 in Drug Discoveries & Therapeutics
Verified
Journal Article
Closed access
PDF file
DEDiaaeldin Mohamed Abdelkawi Elimam
Diaaeldin Mohamed Abdelkawi Elimam
AIAhmed Ibrahim
Ahmed Ibrahim
GLGregory Ing Liou
Gregory Ing Liou
FBFarid Abd-Elrehim Abd-Elaziz Badria
Farid Abd-Elrehim Abd-Elaziz Badria
Aldose reductase (AR) has been the leading target in the treatment of diabetic cataract. Although numerous synthetic AR inhibitors (ARI) have been identified, their adverse side effects currently preclude their use. Olive leaf extract (OLE) as well as ginkgo leaf extract (GLE) are natural supplements that have wide therapeutic indices and a plethora of salutary effects during diabetes that so far untested on sugar cataract progression. As such, the present study sought to evaluate the AR-inhibiting properties of OLE and GLE using the isolated enzyme from rabbit lens. Biochemical analyses revealed that both OLE and GLE inhibited rabbit lens AR activity in a concentration-dependent manner with half maximal inhibitory concentration (IC50) 65 µg/mL and 72.5 µg/mL, respectively. Interestingly, the results of kinetic studies exhibited a differential pattern of inhibition by these two extracts. While an non-competitive inhibition of AR was promoted by OLE recognized by significant decrease in the apparent maximum velocity (Vmax) (0.12 ± 0.009677 µM/min versus 0.278 ± 0.0013677 µM/min) without significant change in Michaelis constant (Km), the GLE showed a competitive pattern of inhibition characterized by significant increase in apparent Km (4.4 ± 0.0068 µM), without change in Vmax value. It would appear that these classes of natural extracts represent effective and safe therapeutic options that hold the great promise for treatment not only diabetic cataract, but also other ocular diseases characterized by uncontrolled AR activity.

30 July 2023 in Neuroglia
Verified
Journal Article
Open access
PDF file
AEAhmed Elshazly
Ahmed Elshazly
MSMelanie Sinanian
Melanie Sinanian
DEDiaaeldin M. Elimam
Diaaeldin M. Elimam
SZSherin Zakaria
Sherin Zakaria
Alzheimer’s disease (AD) is one of the major causes of dementia and its incidence represents approximately 60–70% of all dementia cases worldwide. Many theories have been proposed to describe the pathological events in AD, including deterioration in cognitive function, accumulation of β-amyloid, and tau protein hyperphosphorylation. Infection as well as various cellular molecules, such as apolipoprotein, micro-RNA, calcium, ghrelin receptor, and probiotics, are associated with the disruption of β-amyloid and tau protein hemostasis. This review gives an overview on the integrative cellular and signaling molecules that could play a complementary role in the dysregulation of β-amyloid and tau proteins.

13 March 2023 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
ASAmal Fathy Soliman
Amal Fathy Soliman
DEDiaaeldin M. Elimam
Diaaeldin M. Elimam
Fardous F. El-SendunyFardous F. El-Senduny
Fardous F. El-Senduny
MAManal A. Alossaimi
Manal A. Alossaimi
MAMubarak Alamri
Mubarak Alamri
Fatma M. Abdel BarFatma M. Abdel Bar
Fatma M. Abdel Bar
The major labdanes in the oleogum resin of Araucaria heterophylla (Salisb.) Franco, 13-epi-cupressic acid (1) and acetyl-13-epi-cupressic acid (2) were used to prepare seven new (3–9), along with one known (10) derivatives. RAW264.7 cells were used to evaluate the anti-inflammatory activity of the derivatives (1–10) via measuring the level of COX-2 expression and IL-6. Pre-treated RAW264.7 cells with 1–10 (except for derivative 7) at 25 µM for 24h exhibited downregulation of COX-2 expression in response to LPS stimulation. Moreover, pre-treatment with compounds 1, 2, or 3 significantly attenuated the LPS-stimulated IL-6 level in RAW264.7 cells (p < 0.05). A docking study was conducted against phospholipase A2 (PLA2), a crucial enzyme in initiating the inflammatory cascade. The significant structural features of compounds (1–10) as PLA2 inhibitors included the carbonyl group at C-4 (free or substituted) and the hydrophobic diterpenoid skeleton. This study suggested 13-epi-cupressic acid as a scaffold for new anti-inflammatory agents.